Alzheimer Disease, Early Onset
Neurology·MeSH: Alzheimer Disease
Prevalence
700.0 / 100K
Incidence
120.0 / 100K/yr
4 drugs in development·4 companies·5 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Alzheimer Disease, Early Onset?
BioSniper tracks 4 drugs in development for Alzheimer Disease, Early Onset across 4 companies.
How many clinical trials target Alzheimer Disease, Early Onset?
There are 5 clinical trials targeting Alzheimer Disease, Early Onset tracked by BioSniper.
What is the prevalence of Alzheimer Disease, Early Onset?
The estimated prevalence of Alzheimer Disease, Early Onset is approximately 700.0 per 100,000 population.
Deep-dive into Alzheimer Disease, Early Onset
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis